Growth hormone treatment in hemodialysis patientsA randomized, double-blind, placebo-controlled study

Abstract

Treatment of HD patients with rhGH at a moderate dose causes augmentation of PCRn which is considered to indicate a higher dietary protein intake. The anabolic effect of rhGH seems to be abolished by subclinical inflammation.